Skip to main content
SpringerLink
Log in

The Role of Integrin-Linked Kinase in Cancer Development and Progression

  • Chapter
  • First Online:
Cell-Extracellular Matrix Interactions in Cancer

Abstract

Integrin-Linked Kinase (ILK) is a multifunctional intracellular effector of cell-extracellular matrix interactions. ILK is a central component of focal adhesions and regulates many cellular processes critical for cancer progression, including proliferation, survival, epithelial–mesenchymal transition, migration, invasion, and angiogenesis. The activity and expression of ILK are controlled by a network of intracellular and intercellular processes that result in aberrant ILK expression and signaling in many human malignancies. While the causes of pathologic ILK expression may be varied and remain to be fully elucidated, accumulating evidence supports the targeting of ILK for therapeutic intervention in cancer. Currently, agents designed to interfere with aberrant ILK expression and activity are being evaluated in preclinical models. Interrogation of the ILK interactome using cutting-edge proteomic strategies is also uncovering novel interactions and cellular functions of ILK that may have important implications for the development of effective agents for cancer therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abboud ER, Coffelt SB, Figueroa YG, Zwezdaryk KJ, Nelson AB, Sullivan DE, Morris CB, Tang Y, Beckman BS, Scandurro AB (2007) Integrin-linked kinase: a hypoxia-induced anti-apoptotic factor exploited by cancer cells. Int J Oncol 30:113–122

    CAS  PubMed  Google Scholar 

  • Agouni A, Sourbier C, Danilin S, Rothhut S, Lindner V, Jacqmin D, Helwig JJ, Lang H, Massfelder T (2007) Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B. Carcinogenesis 28:1893–1901

    CAS  PubMed  Google Scholar 

  • Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, Quinn MA (2003) Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. J Pathol 201:229–237

    CAS  PubMed  Google Scholar 

  • Assi K, Mills J, Owen D, Ong C, St Arnaud R, Dedhar S, Salh B (2008) Integrin-linked kinase regulates cell proliferation and tumor growth in murine colitis-associated carcinogenesis. Gut 57:931–940

    CAS  PubMed  Google Scholar 

  • Attwell S, Mills J, Troussard A, Wu C, Dedhar S (2003) Integration of cell attachment, cytoskeletal localization, and signaling by integrin-linked kinase (ILK), CH-ILKBP, and the tumor suppressor PTEN. Mol Biol Cell 14:4813–4825

    CAS  PubMed  Google Scholar 

  • Attwell S, Roskelley C, Dedhar S (2000) The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 19:3811–3815

    CAS  PubMed  Google Scholar 

  • Barbera MJ, Puig I, Dominguez D, Julien-Grille S, Guaita-Esteruelas S, Peiro S, Baulida J, Franci C, Dedhar S, Larue L, Garcia de Herreros A (2004) Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 23:7345–7354

    CAS  PubMed  Google Scholar 

  • Barker TH, Baneyx G, Cardo-Vila M, Workman GA, Weaver M, Menon PM, Dedhar S, Rempel SA, Arap W, Pasqualini R, Vogel V, Sage EH (2005) SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J Biol Chem 280:36483–36493

    CAS  PubMed  Google Scholar 

  • Barry FA, Gibbins JM (2002) Protein kinase B is regulated in platelets by the collagen receptor glycoprotein VI. J Biol Chem 277:12874–12878

    CAS  PubMed  Google Scholar 

  • Basaki Y, Hosoi F, Oda Y, Fotovati A, Maruyama Y, Oie S, Ono M, Izumi H, Kohno K, Sakai K, Shimoyama T, Nishio K, Kuwano M (2007) Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene 26:2736–2746

    CAS  PubMed  Google Scholar 

  • Bendig G, Grimmler M, Huttner IG, Wessels G, Dahme T, Just S, Trano N, Katus HA, Fishman MC, Rottbauer W (2006) Integrin-linked kinase, a novel component of the cardiac mechanical stretch sensor, controls contractility in the zebrafish heart. Genes Dev 20:2361–2372

    CAS  PubMed  Google Scholar 

  • Benoit DS, Tripodi MC, Blanchette JO, Langer SJ, Leinwand LA, Anseth KS (2007) Integrin-linked kinase production prevents anoikis in human mesenchymal stem cells. J Biomed Mater Res A 81:259–268

    PubMed  Google Scholar 

  • Blaheta RA, Weich E, Marian D, Bereiter-Hahn J, Jones J, Jonas D, Michaelis M, Doerr HW, Cinatl J Jr (2006) Human cytomegalovirus infection alters PC3 prostate carcinoma cell adhesion to endothelial cells and extracellular matrix. Neoplasia 8:807–816

    CAS  PubMed  Google Scholar 

  • Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D (2004) Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432:466–472

    CAS  PubMed  Google Scholar 

  • Braun A, Bordoy R, Stanchi F, Moser M, Kostka GG, Ehler E, Brandau O, Fassler R (2003) PINCH2 is a new five LIM domain protein, homologous to PINCHand localized to focal adhesions. Exp Cell Res 284:239–250

    CAS  PubMed  Google Scholar 

  • Bravou V, Klironomos G, Papadaki E, Stefanou D, Varakis J (2003) Integrin-linked kinase (ILK) expression in human colon cancer. Br J Cancer 89:2340–2341

    CAS  PubMed  Google Scholar 

  • Bravou V, Klironomos G, Papadaki E, Taraviras S, Varakis J (2006) ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway. J Pathol 208:91–99

    CAS  PubMed  Google Scholar 

  • Buck MB, Knabbe C (2006) TGF-beta signaling in breast cancer. Ann N Y Acad Sci 1089:119–126

    CAS  PubMed  Google Scholar 

  • Cruet-Hennequart S, Maubant S, Luis J, Gauduchon P, Staedel C, Dedhar S (2003) alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Oncogene 22:1688–1702

    CAS  PubMed  Google Scholar 

  • D’Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze’ev A, Troussard AA, Dedhar S, Pestell RG (2000) The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 275:32649–32657

    PubMed  Google Scholar 

  • Dai DL, Makretsov N, Campos EI, Huang C, Zhou Y, Huntsman D, Martinka M, Li G (2003) Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival. Clin Cancer Res 9:4409–4414

    CAS  PubMed  Google Scholar 

  • Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S (1998) Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A 95:11211–11216

    CAS  PubMed  Google Scholar 

  • Deng JT, Sutherland C, Brautigan DL, Eto M, Walsh MP (2002) Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase. Biochem J 367:517–524

    CAS  PubMed  Google Scholar 

  • Deng JT, Van Lierop JE, Sutherland C, Walsh MP (2001) Ca2 + -independent smooth muscle contraction. A novel function for integrin-linked kinase. J Biol Chem 276:16365–16373

    CAS  PubMed  Google Scholar 

  • Dillon RL, White DE, Muller WJ (2007) The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer. Oncogene 26:1338–1345

    CAS  PubMed  Google Scholar 

  • Dobreva I, Fielding A, Foster LJ, Dedhar S (2008) Mapping the integrin-linked kinase interactome using SILAC. J Proteome Res 7:1740–1749

    CAS  PubMed  Google Scholar 

  • Dougherty GW, Chopp T, Qi SM, Cutler ML (2005) The Ras suppressor Rsu-1 binds to the LIM 5 domain of the adaptor protein PINCH1 and participates in adhesion-related functions. Exp Cell Res 306:168–179

    CAS  PubMed  Google Scholar 

  • Dougherty GW, Jose C, Gimona M, Cutler ML (2008) The Rsu-1-PINCH1–ILK complex is regulated by Ras activation in tumor cells. Eur J Cell Biol 87(8–9):721–734

    CAS  PubMed  Google Scholar 

  • Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE (2005) RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance. Clin Cancer Res 11:3433–3438

    CAS  PubMed  Google Scholar 

  • Edwards LA, Thiessen B, Dragowska WH, Daynard T, Bally MB, Dedhar S (2005) Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth. Oncogene 24:3596–3605

    CAS  PubMed  Google Scholar 

  • Edwards LA, Verreault M, Thiessen B, Dragowska WH, Hu Y, Yeung JH, Dedhar S, Bally MB (2006) Combined inhibition of the phosphatidylinositol 3-kinase/Akt and Ras/mitogen-activated protein kinase pathways results in synergistic effects in glioblastoma cells. Mol Cancer Ther 5:645–654

    CAS  PubMed  Google Scholar 

  • Edwards LA, Woo J, Huxham LA, Verreault M, Dragowska WH, Chiu G, Rajput A, Kyle AH, Kalra J, Yapp D, Yan H, Minchinton AI, Huntsman D, Daynard T, Waterhouse DN, Thiessen B, Dedhar S, Bally MB (2008) Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of Integrin-linked kinase (ILK). Mol Cancer Ther 7:59–70

    CAS  PubMed  Google Scholar 

  • Erdodi F, Kiss E, Walsh MP, Stefansson B, Deng JT, Eto M, Brautigan DL, Hartshorne DJ (2003) Phosphorylation of protein phosphatase type-1 inhibitory proteins by integrin-linked kinase and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun 306:382–387

    CAS  PubMed  Google Scholar 

  • Fielding AB, Dobreva I, Dedhar S (2008a) Beyond focal adhesions: integrin linked kinase associates with tubulin and regulates mitotic spindle organization. Cell Cycle 7(13):1899–1906

    CAS  PubMed  Google Scholar 

  • Fielding AB, Dobreva I, McDonald PC, Foster LJ, Dedhar S (2008b) Integrin-linked kinase localizes to the centrosome and regulates mitotic spindle organization. J Cell Biol 180:681–689

    CAS  PubMed  Google Scholar 

  • Filipenko NR, Attwell S, Roskelley C, Dedhar S (2005) Integrin-linked kinase activity regulates Rac- and Cdc42-mediated actin cytoskeleton reorganization via alpha-PIX. Oncogene 38:5837–5849

    Google Scholar 

  • Fuchs BC, Fujii T, Dorfman JD, Goodwin JM, Zhu AX, Lanuti M, Tanabe KK (2008) Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res 68:2391–2399

    CAS  PubMed  Google Scholar 

  • Fukuda T, Chen K, Shi X, Wu C (2003) PINCH-1 is an obligate partner of integrin-linked kinase (ILK) functioning in cell shape modulation, motility, and survival. J Biol Chem 278:51324–51333

    CAS  PubMed  Google Scholar 

  • Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW, Carter JH (2001) Integrin-linked kinase expression increases with prostate tumor grade. Clin Cancer Res 7:1987–1991

    CAS  PubMed  Google Scholar 

  • Hagan GN, Lin Y, Magnuson MA, Avruch J, Czech MP (2008) A Rictor–Myo1c complex participates in dynamic cortical actin events in 3 T3–L1 adipocytes. Mol Cell Biol 28:4215–4226

    CAS  PubMed  Google Scholar 

  • Hannigan G, Troussard AA, Dedhar S (2005) Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 5:51–63

    CAS  PubMed  Google Scholar 

  • Hannigan GE, Bayani J, Weksberg R, Beatty B, Pandita A, Dedhar S, Squire J (1997) Mapping of the gene encoding the integrin-linked kinase, ILK, to human chromosome 11p15.5–p15.4. Genomics 42:177–179

    CAS  PubMed  Google Scholar 

  • Hannigan GE, Coles JG, Dedhar S (2007) Integrin-linked kinase at the heart of cardiac contractility, repair, and disease. Circ Res 100:1408–1414

    CAS  PubMed  Google Scholar 

  • Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC, Dedhar S (1996) Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 379:91–96

    CAS  PubMed  Google Scholar 

  • Huang HC, Hu CH, Tang MC, Wang WS, Chen PM, Su Y (2007) Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase. Oncogene 26:2781–2790

    CAS  PubMed  Google Scholar 

  • Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW (2007) Epithelial–mesenchymal and mesenchymal–epithelial transitions in carcinoma progression. J Cell Physiol 213:374–383

    CAS  PubMed  Google Scholar 

  • Imanishi Y, Hu B, Jarzynka MJ, Guo P, Elishaev E, Bar-Joseph I, Cheng SY (2007) Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway. Cancer Res 67:4254–4263

    CAS  PubMed  Google Scholar 

  • Ito R, Oue N, Zhu X, Yoshida K, Nakayama H, Yokozaki H, Yasui W (2003) Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma. Virchows Arch 442:118–123

    CAS  PubMed  Google Scholar 

  • Jin L, Tabe Y, Konoplev S, Xu Y, Leysath CE, Lu H, Kimura S, Ohsaka A, Rios MB, Calvert L, Kantarjian H, Andreeff M, Konopleva M (2008) CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells. Mol Cancer Ther 7:48–58

    CAS  PubMed  Google Scholar 

  • Jones J, Marian D, Weich E, Engl T, Wedel S, Relja B, Jonas D, Blaheta RA (2007) CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells. Exp Cell Res 313:4051–4065

    CAS  PubMed  Google Scholar 

  • Joshi MB, Ivanov D, Philippova M, Erne P, Resink TJ (2007) Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3{beta} in endothelial cells. FASEB J 21:3083–3095

    CAS  PubMed  Google Scholar 

  • Kaneko Y, Kitazato K, Basaki Y (2004) Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor. J Cell Sci 117:407–415

    CAS  PubMed  Google Scholar 

  • Kim YB, Choi S, Choi MC, Oh MA, Lee SA, Cho M, Mizuno K, Kim SH, Lee JW (2008) Cell adhesion-dependent cofilin serine 3 phosphorylation by the integrin-linked kinase c–Src complex. J Biol Chem 283:10089–10096

    CAS  PubMed  Google Scholar 

  • Kleeff J, Huang Y, Mok SC, Zimmermann A, Friess H, Buchler MW (2002) Down-regulation of DOC-2 in colorectal cancer points to its role as a tumor suppressor in this malignancy. Dis Colon Rectum 45:1242–1248

    PubMed  Google Scholar 

  • Knoll R, Postel R, Wang J, Kratzner R, Hennecke G, Vacaru AM, Vakeel P, Schubert C, Murthy K, Rana BK, Kube D, Knoll G, Schafer K, Hayashi T, Holm T, Kimura A, Schork N, Toliat MR, Nurnberg P, Schultheiss HP, Schaper W, Schaper J, Bos E, Den Hertog J, van Eeden FJ, Peters PJ, Hasenfuss G, Chien KR, Bakkers J (2007) Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation 116:515–525

    PubMed  Google Scholar 

  • Koul D, Shen R, Bergh S, Lu Y, de Groot JF, Liu TJ, Mills GB, Yung WK (2005) Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma. Mol Cancer Ther 4:1681–1688

    CAS  PubMed  Google Scholar 

  • Kumar AS, Naruszewicz I, Wang P, Leung-Hagesteijn C, Hannigan GE (2004) ILKAP regulates ILK signaling and inhibits anchorage-independent growth. Oncogene 23:3454–3461

    CAS  PubMed  Google Scholar 

  • Lee JM, Dedhar S, Kalluri R, Thompson EW (2006a) The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172:973–981

    CAS  PubMed  Google Scholar 

  • Lee SP, Youn SW, Cho HJ, Li L, Kim TY, Yook HS, Chung JW, Hur J, Yoon CH, Park KW, Oh BH, Park YB, Kim HS (2006b) Integrin-linked kinase, a hypoxia-responsive molecule, controls postnatal vasculogenesis by recruitment of endothelial progenitor cells to ischemic tissue. Circulation 114:150–159

    CAS  PubMed  Google Scholar 

  • Legate KR, Montanez E, Kudlacek O, Fassler R (2006) ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol 7:20–31

    CAS  PubMed  Google Scholar 

  • Leung-Hagesteijn C, Mahendra A, Naruszewicz I, Hannigan GE (2001) Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1. EMBO J 20:2160–2170

    CAS  PubMed  Google Scholar 

  • Li F, Liu J, Mayne R, Wu C (1997) Identification and characterization of a mouse protein kinase that is highly homologous to human integrin-linked kinase. Biochim Biophys Acta 1358:215–220

    CAS  PubMed  Google Scholar 

  • Li Y, Yang J, Dai C, Wu C, Liu Y (2003) Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112:503–516

    CAS  PubMed  Google Scholar 

  • Li Y, Yang J, Luo JH, Dedhar S, Liu Y (2007) Tubular epithelial cell dedifferentiation is driven by the helix-loop-helix transcriptional inhibitor Id1. J Am Soc Nephrol 18:449–460

    PubMed  Google Scholar 

  • Lin SW, Ke FC, Hsiao PW, Lee PP, Lee MT, Hwang JJ (2007) Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system. Exp Cell Res 313:602–613

    CAS  PubMed  Google Scholar 

  • Liu BC, Li MX, Zhang JD, Liu XC, Zhang XL, Phillips AO (2008a) Inhibition of integrin-linked kinase via a siRNA expression plasmid attenuates connective tissue growth factor-induced human proximal tubular epithelial cells to mesenchymal transition. Am J Nephrol 28:143–151

    CAS  PubMed  Google Scholar 

  • Liu BC, Xia HL, Wu JN, Zhang XL, Liu DG, Gong YX (2007a) Influence of irbesartan on expression of ILK and its relationship with epithelial-mesenchymal transition in mice with unilateral ureteral obstruction. Acta Pharmacol Sin 28:1810–1818

    CAS  PubMed  Google Scholar 

  • Liu J, Costello PC, Pham NA, Pintillie M, Jabali M, Sanghera J, Tsao MS, Johnston MR (2006) Integrin-linked kinase inhibitor KP-392 demonstrates clinical benefits in an orthotopic human non-small cell lung cancer model. J Thorac Oncol 1:771–779

    PubMed  Google Scholar 

  • Liu P, Lu J, Cardoso WV, Vaziri C (2008b) The SPARC-related factor SMOC-2 promotes growth factor-induced cyclin D1 expression and DNA synthesis via integrin-linked kinase. Mol Biol Cell 19:248–261

    CAS  PubMed  Google Scholar 

  • Liu XC, Liu BC, Zhang XL, Li MX, Zhang JD (2007b) Role of ERK1/2 and PI3-K in the regulation of CTGF-induced ILK expression in HK-2 cells. Clin Chim Acta 382:89–94

    CAS  PubMed  Google Scholar 

  • Loer B, Bauer R, Bornheim R, Grell J, Kremmer E, Kolanus W, Hoch M (2008) The NHL-domain protein Wech is crucial for the integrin-cytoskeleton link. Nat Cell Biol 10:422–428

    PubMed  Google Scholar 

  • Lynch DK, Ellis CA, Edwards PA, Hiles ID (1999) Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene 18:8024–8032

    CAS  PubMed  Google Scholar 

  • Mackinnon AC, Qadota H, Norman KR, Moerman DG, Williams BD (2002) C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr Biol 12:787–797

    CAS  PubMed  Google Scholar 

  • Marotta A, Parhar K, Owen D, Dedhar S, Salh B (2003) Characterisation of integrin-linked kinase signalling in sporadic human colon cancer. Br J Cancer 88:1755–1762

    CAS  PubMed  Google Scholar 

  • McDonald PC, Fielding AB, Dedhar S (2008a) Integrin-linked kinase–essential roles in physiology and cancer biology. J Cell Sci 121(Pt 19):3121–3132

    CAS  PubMed  Google Scholar 

  • McDonald PC, Oloumi A, Mills J, Dobreva I, Maidan M, Gray V, Wederell ED, Bally MB, Foster LJ, Dedhar S (2008b) Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res 68:1618–1624

    CAS  PubMed  Google Scholar 

  • McPhee TR, McDonald PC, Oloumi A, Dedhar S (2008) Integrin-linked kinase represses E-cadherin expression by regulating PARP-1 binding to the Snail promoter. Dev Dyn 237(10):2737–2747

    CAS  PubMed  Google Scholar 

  • Melchior C, Kreis S, Janji B, Kieffer N (2002) Promoter characterization and genomic organization of the gene encoding integrin-linked kinase 1. Biochim Biophys Acta 1575:117–122

    CAS  PubMed  Google Scholar 

  • Mi Z, Guo H, Wai PY, Gao C, Kuo PC (2006) Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells. Carcinogenesis 27:1134–1145

    CAS  PubMed  Google Scholar 

  • Mo JS, Kim MY, Han SO, Kim IS, Ann EJ, Lee KS, Seo MS, Kim JY, Lee SC, Park JW, Choi EJ, Seong JY, Joe CO, Faessler R, Park HS (2007) Integrin-linked kinase controls Notch1 signaling by down-regulation of protein stability through Fbw7 ubiquitin ligase. Mol Cell Biol 27:5565–5574

    CAS  PubMed  Google Scholar 

  • Mok SC, Chan WY, Wong KK, Cheung KK, Lau CC, Ng SW, Baldini A, Colitti CV, Rock CO, Berkowitz RS (1998) DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene 16:2381–2387

    CAS  PubMed  Google Scholar 

  • Monferran S, Skuli N, Delmas C, Favre G, Bonnet J, Cohen-Jonathan-Moyal E, Toulas C (2008) Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB. Int J Cancer 123:357–364

    CAS  PubMed  Google Scholar 

  • Mongroo PS, Johnstone CN, Naruszewicz I, Leung-Hagesteijn C, Sung RK, Carnio L, Rustgi AK, Hannigan GE (2004) Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer. Oncogene 23:8959–8970

    CAS  PubMed  Google Scholar 

  • Morimoto AM, Tomlinson MG, Nakatani K, Bolen JB, Roth RA, Herbst R (2000) The MMAC1 tumor suppressor phosphatase inhibits phospholipase C and integrin-linked kinase activity. Oncogene 19:200–209

    CAS  PubMed  Google Scholar 

  • Mukherjee K, Sharma M, Urlaub H, Bourenkov GP, Jahn R, Sudhof TC, Wahl MC (2008) CASK Functions as a Mg2 + -independent neurexin kinase. Cell 133:328–339

    CAS  PubMed  Google Scholar 

  • Muranyi A, MacDonald JA, Deng JT, Wilson DP, Haystead TA, Walsh MP, Erdodi F, Kiss E, Wu Y, Hartshorne DJ (2002) Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase. Biochem J 366:211–216

    CAS  PubMed  Google Scholar 

  • Nikolopoulos SN, Turner CE (2001) Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions. J Biol Chem 276:23499–23505

    CAS  PubMed  Google Scholar 

  • Nikolopoulos SN, Turner CE (2002) Molecular dissection of actopaxin-integrin-linked kinase-Paxillin interactions and their role in subcellular localization. J Biol Chem 277:1568–1575

    CAS  PubMed  Google Scholar 

  • Novak A, Hsu SC, Leung-Hagesteijn C, Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R, Dedhar S (1998) Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci U S A 95:4374–4379

    CAS  PubMed  Google Scholar 

  • Obara S, Nakata M, Takeshima H, Katagiri H, Asano T, Oka Y, Maruyama I, Kuratsu J (2004) Integrin-linked kinase (ILK) regulation of the cell viability in PTEN mutant glioblastoma and in vitro inhibition by the specific COX-2 inhibitor NS-398. Cancer Lett 208:115–122

    CAS  PubMed  Google Scholar 

  • Okamura M, Yamaji S, Nagashima Y, Nishikawa M, Yoshimoto N, Kido Y, Iemoto Y, Aoki I, Ishigatsubo Y (2007) Prognostic value of integrin beta1-ILK-pAkt signaling pathway in non-small cell lung cancer. Hum Pathol 38:1081–1091

    CAS  PubMed  Google Scholar 

  • Oloumi A, Syam S, Dedhar S (2006) Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells. Oncogene 25:7747–7757

    CAS  PubMed  Google Scholar 

  • Pasquali C, Bertschy-Meier D, Chabert C, Curchod ML, Arod C, Booth R, Mechtler K, Vilbois F, Xenarios I, Ferguson CG, Prestwich GD, Camps M, Rommel C (2007) A chemical proteomics approach to phosphatidylinositol 3-kinase signaling in macrophages. Mol Cell Proteomics 6:1829–1841

    CAS  PubMed  Google Scholar 

  • Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S (2000) Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci U S A 97:3207–3212

    CAS  PubMed  Google Scholar 

  • Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, Yan J, Sanghera J, Walsh MP, Dedhar S (2001a) Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem 276:27462–27469

    CAS  PubMed  Google Scholar 

  • Persad S, Troussard AA, McPhee TR, Mulholland DJ, Dedhar S (2001b) Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J Cell Biol 153:1161–1174

    CAS  PubMed  Google Scholar 

  • Prud’homme GJ (2007) Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 87:1077–1091

    PubMed  Google Scholar 

  • Quelo I, Gauthier C, Hannigan GE, Dedhar S, St-Arnaud R (2004) Integrin-linked kinase regulates the nuclear entry of the c-Jun coactivator {alpha}-NAC and its coactivation potency. J Biol Chem 279:43893–43899

    CAS  PubMed  Google Scholar 

  • Radeva G, Petrocelli T, Behrend E, Leung-Hagesteijn C, Filmus J, Slingerland J, Dedhar S (1997) Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J Biol Chem 272:13937–13944

    CAS  PubMed  Google Scholar 

  • Rosano L, Spinella F, Di Castro V, Dedhar S, Nicotra MR, Natali PG, Bagnato A (2006) Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma. Mol Cancer Ther 5:833–842

    CAS  PubMed  Google Scholar 

  • Rosano L, Spinella F, Di Castro V, Nicotra MR, Dedhar S, de Herreros AG, Natali PG, Bagnato A (2005) Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Cancer Res 65:11649–11657

    CAS  PubMed  Google Scholar 

  • Rosenberger G, Jantke I, Gal A, Kutsche K (2003) Interaction of alphaPIX (ARHGEF6) with beta-parvin (PARVB) suggests an involvement of alphaPIX in integrin-mediated signaling. Hum Mol Genet 12:155–167

    CAS  PubMed  Google Scholar 

  • Sakai T, Li S, Docheva D, Grashoff C, Sakai K, Kostka G, Braun A, Pfeifer A, Yurchenco PD, Fassler R (2003) Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev 17:926–940

    CAS  PubMed  Google Scholar 

  • Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14:1296–1302

    CAS  PubMed  Google Scholar 

  • Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor–mTOR complex. Science 307:1098–1101

    CAS  PubMed  Google Scholar 

  • Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T (2006) Integrin-linked kinase activity is associated with interleukin-1 alpha-induced progressive behavior of pancreatic cancer and poor patient survival. Oncogene 25:3237–3246

    CAS  PubMed  Google Scholar 

  • Segrelles C, Lu J, Hammann B, Santos M, Moral M, Cascallana JL, Lara MF, Rho O, Carbajal S, Traag J, Beltran L, Martinez-Cruz AB, Garcia-Escudero R, Lorz C, Ruiz S, Bravo A, Paramio JM, DiGiovanni J (2007) Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis. Cancer Res 67:10879–10888

    CAS  PubMed  Google Scholar 

  • Segrelles C, Moral M, Lara MF, Ruiz S, Santos M, Leis H, Garcia-Escudero R, Martinez-Cruz AB, Martinez-Palacio J, Hernandez P, Ballestin C, Paramio JM (2006) Molecular determinants of Akt-induced keratinocyte transformation. Oncogene 25:1174–1185

    CAS  PubMed  Google Scholar 

  • Segrelles C, Ruiz S, Perez P, Murga C, Santos M, Budunova IV, Martinez J, Larcher F, Slaga TJ, Gutkind JS, Jorcano JL, Paramio JM (2002) Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene 21:53–64

    CAS  PubMed  Google Scholar 

  • Shi Q, Bao S, Song L, Wu Q, Bigner DD, Hjelmeland AB, Rich JN (2007) Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases. Oncogene 26:4084–4094

    CAS  PubMed  Google Scholar 

  • Shimizu M, Kondo S, Urushihara M, Takamatsu M, Kanemoto K, Nagata M, Kagami S (2006) Role of integrin-linked kinase in epithelial-mesenchymal transition in crescent formation of experimental glomerulonephritis. Nephrol Dial Transplant 21:2380–2390

    CAS  PubMed  Google Scholar 

  • Somasiri A, Howarth A, Goswami D, Dedhar S, Roskelley CD (2001) Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells. J Cell Sci 114:1125–1136

    CAS  PubMed  Google Scholar 

  • Tabe Y, Jin L, Tsutsumi-Ishii Y, Xu Y, McQueen T, Priebe W, Mills GB, Ohsaka A, Nagaoka I, Andreeff M, Konopleva M (2007) Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells. Cancer Res 67:684–694

    CAS  PubMed  Google Scholar 

  • Takada T, Noguchi T, Inagaki K, Hosooka T, Fukunaga K, Yamao T, Ogawa W, Matozaki T, Kasuga M (2002) Induction of apoptosis by stomach cancer-associated protein-tyrosine phosphatase-1. J Biol Chem 277:34359–34366

    CAS  PubMed  Google Scholar 

  • Takanami I (2005) Increased expression of integrin-linked kinase is associated with shorter survival in non-small cell lung cancer. BMC Cancer 5:1

    PubMed  Google Scholar 

  • Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros AG, Dedhar S (2001) Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC−/− human colon carcinoma cells. Oncogene 20:133–140

    CAS  PubMed  Google Scholar 

  • Tan C, Cruet-Hennequart S, Troussard A, Fazli L, Costello P, Sutton K, Wheeler J, Gleave M, Sanghera J, Dedhar S (2004a) Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell 5:79–90

    CAS  PubMed  Google Scholar 

  • Tan NS, Michalik L, Di-Poi N, Desvergne B, Wahli W (2004b) Critical roles of the nuclear receptor PPARbeta (peroxisome-proliferator-activated receptor beta) in skin wound healing. Biochem Soc Trans 32:97–102

    CAS  PubMed  Google Scholar 

  • Troussard AA, Costello P, Yoganathan TN, Kumagai S, Roskelley CD, Dedhar S (2000) The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene 19:5444–5452

    CAS  PubMed  Google Scholar 

  • Troussard AA, McDonald PC, Wederell ED, Mawji NM, Filipenko NR, Gelmon KA, Kucab JE, Dunn SE, Emerman JT, Bally MB, Dedhar S (2006) Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival. Cancer Res 66:393–403

    CAS  PubMed  Google Scholar 

  • Tu Y, Huang Y, Zhang Y, Hua Y, Wu C (2001) A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading. J Cell Biol 153:585–598

    CAS  PubMed  Google Scholar 

  • Tu Y, Li F, Goicoechea S, Wu C (1999) The LIM-only protein PINCH directly interacts with integrin-linked kinase and is recruited to integrin-rich sites in spreading cells. Mol Cell Biol 19:2425–2434

    CAS  PubMed  Google Scholar 

  • Tu Y, Li F, Wu C (1998) Nck-2, a novel Src homology2/3-containing adaptor protein that interacts with the LIM-only protein PINCH and components of growth factor receptor kinase-signaling pathways. Mol Biol Cell 9:3367–3382

    CAS  PubMed  Google Scholar 

  • Velyvis A, Yang Y, Wu C, Qin J (2001) Solution structure of the focal adhesion adaptor PINCH LIM1 domain and characterization of its interaction with the integrin-linked kinase ankyrin repeat domain. J Biol Chem 276:4932–4939

    CAS  PubMed  Google Scholar 

  • Wang SC, Makino K, Xia W, Kim JS, Im SA, Peng H, Mok SC, Singletary SE, Hung MC (2001) DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway. Oncogene 20:6960–6964

    CAS  PubMed  Google Scholar 

  • Watzka SB, Setinek U, Huber M, Cantonati H, Lax F, Watson S, Weigel G, Muller MR (2008) Reactivity of integrin-linked kinase in human mesothelial cell proliferation. Interact Cardiovasc Thorac Surg 7:107–110

    PubMed  Google Scholar 

  • White DE, Cardiff RD, Dedhar S, Muller WJ (2001) Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene 20:7064–7072

    CAS  PubMed  Google Scholar 

  • Wilson DP, Sutherland C, Borman MA, Deng JT, Macdonald JA, Walsh MP (2005) Integrin-linked kinase is responsible for Ca2 + -independent myosin diphosphorylation and contraction of vascular smooth muscle. Biochem J 392:641–648

    CAS  PubMed  Google Scholar 

  • Wong RP, Ng P, Dedhar S, Li G (2007) The role of integrin-linked kinase in melanoma cell migration, invasion, and tumor growth. Mol Cancer Ther 6:1692–1700

    CAS  PubMed  Google Scholar 

  • Wu C, Keightley SY, Leung-Hagesteijn C, Radeva G, Coppolino M, Goicoechea S, McDonald JA, Dedhar S (1998) Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J Biol Chem 273:528–536

    CAS  PubMed  Google Scholar 

  • Xie D, Yin D, Tong X, O’Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP (2004) Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res 64:1987–1996

    CAS  PubMed  Google Scholar 

  • Xu X, Rongali SC, Miles JP, Lee KD, Lee M (2006) pat-4/ILK and unc-112/Mig-2 are required for gonad function in Caenorhabditis elegans. Exp Cell Res 312:1475–1483

    CAS  PubMed  Google Scholar 

  • Yamaji S, Suzuki A, Kanamori H, Mishima W, Yoshimi R, Takasaki H, Takabayashi M, Fujimaki K, Fujisawa S, Ohno S, Ishigatsubo Y (2004) Affixin interacts with alpha-actinin and mediates integrin signaling for reorganization of F-actin induced by initial cell-substrate interaction. J Cell Biol 165:539–551

    CAS  PubMed  Google Scholar 

  • Yamaji S, Suzuki A, Sugiyama Y, Koide Y, Yoshida M, Kanamori H, Mohri H, Ohno S, Ishigatsubo Y (2001) A novel integrin-linked kinase-binding protein, affixin, is involved in the early stage of cell-substrate interaction. J Cell Biol 153:1251–1264

    CAS  PubMed  Google Scholar 

  • Yasunaga T, Kusakabe M, Yamanaka H, Hanafusa H, Masuyama N, Nishida E (2005) Xenopus ILK (integrin-linked kinase) is required for morphogenetic movements during gastrulation. Genes Cells 10:369–379

    CAS  PubMed  Google Scholar 

  • Yau CY, Wheeler JJ, Sutton KL, Hedley DW (2005) Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts. Cancer Res 65:1497–1504

    CAS  PubMed  Google Scholar 

  • Younes MN, Kim S, Yigitbasi OG, Mandal M, Jasser SA, Dakak Yazici Y, Schiff BA, El-Naggar A, Bekele BN, Mills GB, Myers JN (2005) Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer. Mol Cancer Ther 4:1146–1156

    CAS  PubMed  Google Scholar 

  • Younes MN, Yigitbasi OG, Yazici YD, Jasser SA, Bucana CD, El-Naggar AK, Mills GB, Myers JN (2007) Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 133:15–23

    PubMed  Google Scholar 

  • Zervas CG, Gregory SL, Brown NH (2001) Drosophila integrin-linked kinase is required at sites of integrin adhesion to link the cytoskeleton to the plasma membrane. J Cell Biol 152:1007–1018

    CAS  PubMed  Google Scholar 

  • Zhang Y, Chen K, Guo L, Wu C (2002a) Characterization of PINCH-2, a new focal adhesion protein that regulates the PINCH-1-ILK interaction, cell spreading, and migration. J Biol Chem 277:38328–38338

    CAS  PubMed  Google Scholar 

  • Zhang Y, Chen K, Tu Y, Wu C (2004) Distinct roles of two structurally closely related focal adhesion proteins, {alpha}-parvins and {beta}-parvins, in regulation of cell morphology and survival. J Biol Chem 279:41695–41705

    CAS  PubMed  Google Scholar 

  • Zhang Y, Guo L, Chen K, Wu C (2002b) A critical role of the PINCH-integrin-linked kinase interaction in the regulation of cell shape change and migration. J Biol Chem 277:318–326

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was funded by grants from the Canadian Institutes of Health Research (CIHR), National Cancer Institute of Canada with funds from the Terry Fox Foundation and the Canadian Breast Cancer Research Alliance with special funding support from the Canadian Breast Cancer Foundation and the Cancer Research Society.

Author information

Authors and Affiliations

  1. Department of Cancer Genetics, British Columbia Cancer Agency, BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada

    Shoukat Dedhar

Authors
  1. Paul C. McDonald
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shoukat Dedhar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shoukat Dedhar .

Editor information

Editors and Affiliations

  1. Vanderbilt University Medical Center, Department of Medicine, Nashville, 37232, U.S.A.

    Roy Zent

  2. Medical Center, Vanderbilt University, Nashville, 37232, U.S.A.

    Ambra Pozzi

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

McDonald, P.C., Dedhar, S. (2010). The Role of Integrin-Linked Kinase in Cancer Development and Progression. In: Zent, R., Pozzi, A. (eds) Cell-Extracellular Matrix Interactions in Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0814-8_11

Download citation

Publish with us

Policies and ethics

Search

Navigation